https://www.ibtomato.com/ExternalView.aspx?type=1&no=19472IB토마토ko2026-09-08T17:24:47+09:00한라캐스트, 수주 9207억 쌓였는데 현금 81억…유동성 '빨간불'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19448IB토마토ko2026-09-08T16:56:50+09:00한세실업, 과테말라 공장 가동 코앞인데…현금흐름 '역주행'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19470IB토마토ko2026-09-08T17:39:17+09:00펄어비스, 등기이사 상여 120배 급증…보수위 없는 '성과 잔치'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19460IB토마토ko2026-09-08T15:10:55+09:00카카오페이증권, 계좌 850만인데 거래 고객 161만…AI 승부수https://www.ibtomato.com/ExternalView.aspx?type=1&no=19467IB토마토ko2026-09-08T14:58:05+09:00마곡 디어반, 현장은 북적이는데…미분양 317억·차입금 817억https://www.ibtomato.com/ExternalView.aspx?type=1&no=19466IB토마토ko2026-09-08T14:51:59+09:00대명에너지, 풍력 SPC 담보 3619억…곡성·안마 차질에 회수 '경고등'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19464IB토마토ko2026-09-08T10:35:13+09:00고려아연, 분기마다 1000억 푼다…배당 재원은 충분할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19451IB토마토ko2026-09-07T18:14:33+09:00(3% 금리의 명암)③증시서 빠진 35조…은행권 수신 경쟁 불붙나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19486IB토마토ko2026-09-09T18:20:36+09:00(IPO인사이트)바로팜, 약국 2.4만곳 확보…2413억 몸값 통할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19491IB토마토ko2026-09-09T18:12:35+09:00농심, 적자에도 이스포츠·수제맥주…왜 계속할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19490IB토마토ko2026-09-09T18:06:37+09:00(공시톺아보기)비상장사 합병인데 외부평가 없다…왜?https://www.ibtomato.com/ExternalView.aspx?type=1&no=19485IB토마토ko2026-09-09T14:07:38+09:00(크레딧시그널)한국서부발전, 적자 속 3.5조 발전소 투자 '부담'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19459IB토마토ko2026-09-07T18:05:24+09:00강원에너지, 매출 82% 리튬에 쏠렸다…원가 상승에 수익성 '흔들'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19458IB토마토ko2026-09-07T17:47:54+09:00삼성전자, 90조 투자하고도 현금 '두둑'…80조 추가 환원 촉각https://www.ibtomato.com/ExternalView.aspx?type=1&no=19457IB토마토ko2026-09-07T17:43:23+09:00흥국화재, 자본비율 기준 미달…1200억원 상환까지 '설상가상'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19455IB토마토ko2026-09-07T17:36:34+09:00시지트로닉스, 4년째 팔수록 손해…현금 98% 소진https://www.ibtomato.com/ExternalView.aspx?type=1&no=19454IB토마토ko2026-09-07T17:28:18+09:00에이프로젠바이오로직스, 사용처는 '백지'…발행주식 78% 유증 강행https://www.ibtomato.com/ExternalView.aspx?type=1&no=19450IB토마토ko2026-09-07T17:15:44+09:00(IPO 새판짜기)①90%가 밴드 상단…공모가 '뻥튀기' 논란https://www.ibtomato.com/ExternalView.aspx?type=1&no=19442IB토마토ko2026-09-07T16:09:28+09:00LG전자, 전장 실적 확대에도…핵심 자회사 'ZKW' 재무 악화 https://www.ibtomato.com/ExternalView.aspx?type=1&no=19473IB토마토ko2026-09-09T06:10:00+09:00(데스크칼럼)밤 8시까지 열리는 증시…투자자 보호도 연장됐나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19449IB토마토ko2026-09-07T13:56:17+09:00한라엔컴, 골재업체 인수 이어 석산 물색…불황 속 '역발상 투자'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19471IB토마토ko2026-09-08T17:11:44+09:00(IPO인사이트)엠에스바이오, 312억 공모 승부…생산능력 두 배로https://www.ibtomato.com/ExternalView.aspx?type=1&no=19469IB토마토ko2026-09-08T16:18:36+09:00(유증레이다)큐리언트, 관리종목 피하려 유증…주주 희석 불가피https://www.ibtomato.com/ExternalView.aspx?type=1&no=19468IB토마토ko2026-09-08T16:00:09+09:00(크레딧시그널)BS한양, 실적 성장에도…차입금 9000억 육박